Research Article

Gender Differences in Ghrelin Association with Cardiometabolic Risk Factors in Arab Population

Table 1

Clinical and sociodemographic characteristics of the study population.

CharacteristicsAll ( = 359)Female ()Male () value

Age (years)44.4 ± 11.544.2 ± 11.844.9 ± 11.10.5481
BMI (kg/m2)31.6 ± 0.3433.3 ± 0.4830.6 ± 0.45<0.0001
Waist circumference (cm)101.2 ± 0.7599.39 ± 1.03103.1 ± 1.090.0186
SBP (mmHg)129.8 ± 1.01124.8 ± 1.41135.1 ± 1.36<0.0001
DBP (mmHg)78.3 ± 0.6476.89 ± 0.9079.77 ± 0.900.0242
FBG (mmol/l)6.23 ± 0.165.93 ± 0.186.57 ± 0.270.0366
HbA1c (%)6.04 ± 0.095.67 ± 0.106.46 ± 0.15<0.0001
HOMA-IR3.31 ± 0.513.46 ± 0.343.13 ± 0.230.5621
TC (mmol/l)5.20 ± 0.065.32 ± 0.085.08 ± 0.090.0316
TG (mmol/l)1.70 ± 0.061.54 ± 0.061.88 ± 0.110.0050
HDL (mmol/l)1.13 ± 0.021.26 ± 0.030.99 ± 0.02<0.0001
LDL (mmol/l)3.36 ± 0.053.42 ± 0.073.30 ± 0.080.2122
Ghrelin (pg/ml)860 (240–5360)960 (240–4090)750 (290–5360)0.0049

BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; FBG: fasting blood glucose; TC: total cholesterol; TG: triglycerides; HDL: high-density lipoprotein; LDL: low-density lipoprotein.
Results are reported as mean ± SE except for nonnormally distributed ghrelin levels that are presented as median (range).